Boy Wirat/iStock via Getty Images
Hims & Hers (NYSE:HIMS) is a good long-term, high-growth, though higher-risk investment. I own it and plan to add more on declines and keep it for 3-5 years, hoping to double my investment with a 3-year target
Hims & Hers: An Excellent Subscription Business
Summary
- Hims & Hers offers a high-growth, recurring subscription telehealth business with strong user and revenue growth, expanding into multiple health segments.
- It is the market leader in telehealth easily outpacing its competition.
- The trend among millenials and Gen Z patients towards digital health should ensure Hims sustaining its pole position.
- Despite risks and recent price surges, I plan to hold HIMS for 3-5 years, believing in its long-term potential as a leading telehealth provider.
Financial Analyst and Portfolio Manager for over 3 decades, with a 5 Star TipRanks rating in the top 3%.I love to find great, undervalued, best-in-class companies using the same fundamental analysis and strategies used by Warren Buffett and Peter Lynch.
Analyst’s Disclosure:I/we have a beneficial long position in the shares of HIMS, AMZN,NVO either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.
Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.